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Abstract
Background: Data on intra-abdominal hypertension [IAH] and secondary abdominal compartment syndrome [ACS]
due to neurological insults are limited.
Methods: This was a prospective observational study conducted between January 2010 and January 2011 in the
neurological ICU [NICU]. Forty-one consecutive patients with sellar region tumors [SRT] were enrolled into the
study. If conservative therapy was ineffective in patients with ACS, thoracic epidural anesthesia [EA] was performed.
Primary endpoint was defined as the efficacy of conservative treatment and EA in patients with IAH and ACS;
secondary endpoint, the influence of IAH and ACS on outcomes.
Results: Of the 41 patients, 13 (31.7%) had normal intra-abdominal pressure and 28 (68.3%) developed IAH, of
whom 9 (22%) had ACS (group II). On average, IAH developed on the second postoperative day, while ACS,
between the third and the fifth day. Multiple organ dysfunction developed in 3 (23.1%) patients of group I and in
23 (82%) patients of group II (p = 0.0003). Ileus due to gastrointestinal dysmotility was present in 6 (46.2%) patients
of group I and in all patients of group II (p = 0.0001). Significant risk factors for ileus were diencephalon
dysfunction (whole group - in 33 patients (80.5%); group I - in 6 patients (46.2%); group II - in 27 patients (96.4%),
p = 0.0002) and sepsis (whole group - in 8 patients (19.5%); group I - no cases; group II - in 8 patients (28.6%), p =
0.03). Conservative treatment was effective in the majority of patients (78.9%) with IAH and only in 3 (33%) patients
with ACS. Thoracic EA was performed in four patients with ACS with success. Length of stay in the NICU was 6.5 ±
4.6 days in group I and 24.1 ± 25.7 (p = 0.02) days in group II. Five out of nine (55.6%) patients with ACS died.
None of these patients received EA. All patients with EA had favorable outcomes.
Conclusion: The development of IAH is common after SRT surgery. If conservative treatment is ineffective, EA can
be considered in patients with secondary ACS. Further studies are warranted.
Introduction
Intra-abdominal hypertension [IAH] is associated with
increased morbidity and mortality in critically ill patients
[1-3]. Abdominal compartment syndrome [ACS] leads
to multiple organ dysfunction [MOD] and carries a high
mortality [4,5]. Ileus is considered as a contributing fac-
tor leading to IAH [1]. Patients with recent removal of
sellar region tumors [SRT] represent a special neurocri-
tical care population because they have an increased risk
of postoperative ileus [4].
The ideal management for secondary ACS has not yet
been well defined [6,7]. The evidence-based therapeutic
options are scarce [5,8]. The consensus conference on
IAH and ACS recommends to maintain an abdominal
perfusion pressure [APP] above 50 to 60 mmHg (grade
1C), to use a brief trial of neuromuscular blockage (grade
2C), to avoid elevation of the head of the bed above 30°
(grade 2C), and to use hypertonic crystalloid and colloid-
based resuscitation fluids (grade 1C) [5]. The benefit of
analgesia/sedation, prokinetic motility agents, and naso-
gastric/colonic decompression is unclear [5]. Intra-
abdominal pressure [IAP] should be decreased before it
reaches the threshold that will lead to the development
of irreversible MOD. Urgent abdominal decompression is
recommended in patients in whom medical treatment for
* Correspondence: Stan.Popugaev@yahoo.com
Department of Neurological Intensive Care Unit (NICU), Burdenko
Neurosurgical Research Institute, 16 4th Tverskaya-Yamskaya, Moscow,
125047, Russia
Popugaev et al. Annals of Intensive Care 2012, 2(Suppl 1):S2
http://www.annalsofintensivecare.com/content/2/S1/S2
© 2012 Popugaev et al.; licensee Springer This is an open access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.ACS has failed [9]. In spite of the relative safety and abso-
lute efficacy of abdominal decompression, this operation
has inherent risks and morbidity [8]. Prolonged thoracic
epidural anesthesia [EA] has been shown to be effective
in the reduction of IAP in patients with primary ACS
[10]. To date, there are no data on the efficacy of EA in
patients with secondary ACS. The purpose of the study
was (1) to investigate the incidence of raised IAP in the
postoperative period in SRT patients, (2) to evaluate the
efficacy of conservative treatment in IAH and (3) to eval-
uate the efficacy of EA as a treatment option for ACS.
Methods
Study patients and definitions
Between January 2010 and January 2011, a prospective
observational study was conducted in the 38-bed neuro-
logical intensive care unit [NICU] of Burdenko Neuro-
surgical Research Institute, Moscow, Russia. Inclusion
criteria were: (1) adult patients, (2) SRT, and (3) a com-
plicated postoperative period. Exclusion criteria were:
(1) deep coma, (2) phimosis or contraindication for
bladder pressure measurement, and (3) a contracted
bladder. Patients were selected consecutively. All conse-
cutive patients who met the inclusion criteria were
included into the study. The study was conducted in
accordance with the study protocol, the Declaration of
Helsinki, and applicable regulatory requirements. The
institutional review board and the local institutional
ethics committee approved the protocol. Informed con-
sent was obtained from each patient before inclusion.
A complicated postoperative period was recognized if
the patient had an unstable neurological status or a new
organ dysfunction. The clinical picture in SRT patients
is typically a combination of altered level of conscious-
ness, water and electrolyte disturbances (fluid balance
dysregulation with hyper- or hyponatremia in the
absence of iatrogenic causes, such as inadequate use of
desmopressin, vaptans (V2-receptor antagonists), or
hyperosmotic solutions), and at least one new organ
dysfunction/failure as defined by a sequential organ fail-
ure assessment [SOFA] subscore equal to or above 3
[4]. This entity has been defined previously as dience-
phalon dysfunction [DD].
IAH is defined as a sustained elevation of IAP equal to
or above 12 mmHg, and ACS is defined as a sustained
increase in IAP over 20 mmHg that is associated with a
new organ dysfunction/failure [2]. The APP is calculated
as mean arterial pressure minus IAP.
One of the causes of IAH and secondary ACS is gastro-
intestinal dysmotility resulting in ascites and ileus. Ileus
has been classified into three forms: (1) impaired gastric
emptying, (2) impaired intestinal/colonic emptying, (3) or
both. Impaired gastric emptying is defined as a gastric
residual volume above 400 ml per day (gastrostasis) with
preserved intestinal peristalsis and defecation. Impaired
intestinal/colonic emptying is defined as preserved gastric
emptying with depressed intestinal peristalsis and consti-
pation. Gastrostasis, depressed intestinal peristalsis, and
constipation comprise the combined form of ileus. Out-
comes were evaluated with the Glasgow Outcome Scale
[GOS] (Table 1).
Patient management
Severity scores (acute physiology and chronic health
evaluation [APACHE]-II and SOFA) were recorded in
all patients admitted to NICU. Routine CT imaging of
the brain was performed immediately postsurgery. Most
patients were ventilated, and crystalloids or colloids and
sympathomimetics were started early when indicated
and to maintain perfusion pressure [4].
All patients received polyhormonal replacement ther-
apy with glucocorticoids (hydrocortisone 150 to 200
mg/day which gradually decrease to 30 mg/day, orally)
and thyroid hormones (L-thyroxin 1 to 3 μg/kg/day,
orally or IV). Central diabetes insipidus was corrected
with desmopressin.
All physiological, clinical, and biochemical data were
collected. All patients were assessed with APACHE-II
and SOFA scores.
IAP, APP measurement, and IAH management
IAP was measured every 6 h from the second postopera-
tive day and during ICU stay, or until the 28th post-
operative day. Measurements were carried out via the
bladder with an installation volume of 25 ml sterile sal-
ine. Urinary catheter was connected to a Philips MP60
(Eindhoven, The Netherlands) monitor via a standard
pressure transducer [11]. The APP was registered
simultaneously.
All the patients underwent ultrasound investigation in
order to rule out ascites. Patients were screened for IAH
risk factors according to an international consensus [2].
Risk factors for ileus were considered to be either inde-
pendent or related to the presence of DD. Independent
risk factors are the use of narcotic analgetics, sympatho-
mimetics, positive fluid balance, sepsis, and hypokalemia.
Conservative treatment of IAH was started immediately
in accordance to the IAH/ACS medical management
algorithm [5,12]. If conservative treatment was ineffective
in patients with ACS for longer than a 24-h period, thor-
acic EA was performed via an 18-gauge epidural catheter
t h a tw a si n s e r t e da tt h el e v e lo fT 8t oT 9t h r o u g ha
Touhy needle and advanced up to 5 to 6 cm in a cepha-
lad direction. After confirmation of catheter position, a
0.25% bupivacaine infusion at 7 to 8 ml/h was initiated
and titrated. The EA remained in place for 3 days. Sepsis
was a contraindication for EA. According to our depart-
ment protocol, treatment of IAH was considered effective
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considered effective if IAP normalized within 24 h.
Statistical methods
The primary endpoint was defined as the efficacy of
conservative treatment and EA to lower IAP in patients
with IAH and ACS. The secondary endpoint was
defined as the influence of IAP and ACS on the out-
come. Descriptive analyses were performed for all study
variables. Data are presented as mean and standard
deviation. We used variance analysis, c
2 (Pearson’sa n d
maximum likelihood chi-square), and Fisher’se x a c tt e s t
in the analysis of contingency tables. We also calculated
the relative risk when appropriate. A p value of < 0.05
was defined as a significant difference. For this purpose,
we used program Statistica v6 (StatSoft Inc., Tulsa, OK,
USA).
Results
Patient characteristics and patient groups
Five hundred and seventy-eight SRT patients underwent
tumor removal during the study period. Five hundred
and thirty-four patients were excluded because they had
a normal postoperative period; another three patients
were excluded because they developed deep coma on the
second postoperative day. The remaining 41 patients
were enrolled. The IAP was normal in 13 patients (group
I). IAH developed in 28 patients (group II, Figure 1).
Baseline APACHE-II and SOFA scores for group II
patients indicate that their condition was more severe at
the time of NICU admission (Table 2).
IAP and APP
The majority of patients were admitted to NICU without
IAH. In group I, IAP was significantly lower than in
group II, 6.5 ± 3.1 mmHg versus 10.6 ± 3.9 mmHg (p =
0.003, Table 2). In group I, the duration of IAP monitor-
ing was 5.6 ± 4.8 days; in group II, it was 14.9 ± 8.5 days.
T h eI A Pw a ss i g n i f i c a n t l yh i g h e ri ng r o u pI If r o mt h e
second to the sixth postoperative day. Maximal IAP was
8.9 ± 2.3 mmHg in group I and 18.6 ± 5.6 mmHg in
group II. In group II, maximal IAP developed on 2.5 ±
0.9 postoperative day; in group I, significantly later - on
6.2 ± 0.9 postoperative day (p = 0.01). ACS developed in
nine patients. On average, IAH developed on the second
postoperative day, while ACS, between the third and the
Table 1 Glasgow Outcome Scale
GOS Outcome Functional outcome
1 Dead Unfavorable
2 Vegetative state
3 Severely disabled (conscious but requires others for daily support)
4 Moderately disabled (independent but disabled) Favorable
5 Good recovery (resumed most normal activity)
Figure 1 Mean IAP in groups I and II during the first seven days of postoperative period.
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Whole
group
Group I (no
IAH)
Group II
(IAH)
p Value (significance of difference between groups I
and II)
Number (patients) 41 13 28
Sex (male/female) 19:22 8:5 11:17 0.2
Age (mean ± SD) 48.3 ± 15 46.3 ± 17.7 49.3 ± 13.8 0.8
APACHE-II (mean ± SD) 13 ± 5.6 9.1 ± 6.1 14.9 ± 4.4 0.0004*
SOFA score (mean ± SD) 2.5 ± 1.8 1.9 ± 2.3 2.7 ± 1.6 0.2
Neurosurgical pathology (patients)
Pituitary adenoma 18 6 12 0.8
Craniopharyngioma 11 1 10 0.06
Sellar region meningioma 8 3 5 0.7
III ventricular glioma 3 2 1 0.2
III ventricular ganglioma 1 1 0 0.1
Admission value of IAP
(mmHg, mean ± SD)
9.2 ± 4.0 6.5 ± 3.1 10.6 ± 3.9 0.003*
Mean value of IAP mmHg
(mean ± SD)
9.3 ± 3.1 6.4 ± 2.0 10.7 ± 2.5 0.000003*
Maximal value of IAP
(mmHg, mean ± SD)
15.2 ± 6.2 8.9 ± 2.3 18.6 ± 5.6 0.002*
Minimal value of APP
(mmHg, mean ± SD)
79.0 ± 9.0 86.5 ± 5.8 75.6 ± 8.2 0.0001*
Risk factors for IAH (patients (%))
Positive fluid balance 7 (17.1) 1 (7.7) 6 (21.4) 0.3
Acidosis 2 (4.9 0 (0) 2 (7.1) 0.3
Hypothermia 4 (9.8) 1 (7.7) 3 (10.7) 0.7
Coagulopathy 6 (14.6) 1 (7.7) 5 (17.9) 0.4
MOD 26 (63.4) 3 (23.1) 23 (82) 0.0003*
MV 24 (58.5) 6 (46.2) 18 (64.3) 0.3
Ileus 34 (82.9) 6 (46.2) 28 (100) 0.0001*
Type of ileus (patients (%))
Impaired gastric emptying - - -
Impaired intestinal and colonic
emptying
21 (51.2) 4 (30.8) 17 (60.7) 0.07
Combined form 13 (31.7) 2 (15.4) 11 (39.3) 0.1
Onset time of ileus
(postoperative day)
2.3 ± 1.4 1.7 ± 0.5 2.4 ± 1.5 0.17
Duration of ileus (days) 10.6 ± 7.6 4.3 ± 1.0 11.9 ± 7.7 0.01*
Risk factors of ileus (patients (%))
DD 33 (80.5) 6 (46.2) 27 (96.4) 0.0002*
Independent risk factors
(patients (%))
Narcotics 2 (4.9) 0 (0) 2 (7.1) 0.3
Sympathomimetics 7 (17.1) 5 (38.5) 2 (7.1) 0.01*
Positive fluid balance 7 (17.1) 1 (7.7) 6 (21.4) 0.3
Sepsis 8 (19.5) 0 (0) 8 (28.6) 0.03*
Hypokalemia, hypomagnesaemia 28 (68.3) 8 (61.5) 20 (71.4) 0.5
LOS (days, mean ± SD) 18.5 ± 22.8 6.5 ± 4.6 24.1 ± 25.7 0.02*
Outcome (patients (%))
Favorable outcome GOS 4 26 (63.4) 11 (85) 15 (54) 0.06
Unfavorable outcome 15 (36.6) 2 (15) 13 (46) 0.06
GOS 2,3 4 (9.8) 0 (0) 4 (14)
GOS 1 11 (26.8) 2 (15) 9 (32)
*Significant difference. IAH, intra-abdominal hypertension; SD, standard deviation; APACHE-II, acute physiology and chronic health evaluation, and SOFA,
sequential organ failure assessment, scores on ICU admission; IAP, intra-abdominal pressure; APP, abdominal perfusion pressure; MOD, multiple organ
dysfunction; MV, mechanical ventilation; GOS, Glasgow Outcome Scale; LOS, length of stay.
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Page 4 of 8fifth day. Minimal APP was normal in both groups, how-
ever, it was significantly higher in group I - 86.5 ± 5.8
mmHg versus 75.6 ± 8.2 mmHg in group II (p = 0.0001).
Causes of IAH and types of ileus
None of the patients developed ascites. Ileus was the
most common risk factor for IAH in both groups, 46.2%
and 100%, respectively. MOD and the need for mechani-
cal ventilation [MV] for more than 24 h occurred also
more frequently in group II (Table 2). Ileus developed
within the first two postoperative days, and its onset time
did not differ between groups (p = 0.17). Duration of
ileus was significantly longer in group II (p = 0.01). There
were no cases with isolated impaired gastric emptying.
The impaired intestinal and colonic emptying was diag-
nosed in 4 patients of group I and in 17 patients of group
II (p = 0.07). An interesting observation was that ileus
developed prior to IAH, but it lasted longer.
A major cause of ileus was DD. DD developed in 46.2%
cases of group I and in 96.4% cases of group II. Among
the list of independent risk factors, electrolyte disorders
and sympathomimetics werec o m m o ni nb o t hg r o u p s
(Table 2).
Diencephalon dysfunction
DD significantly increased the risk for IAH development
(relative risk 6.56, 95% confidence interval 1.04 to
16.46).
Therapy of IAH and ACS
Conservative treatment was effective in 15 patients out of
19 (79%) with IAH, but without ACS and in 3 patients out
of 9 (33%) with ACS. EA was performed in four cases with
ACS. In all these cases, EA effectively normalized IAP
rapidly after bupivacaine infusion. No complications were
associated with EA. In three ACS cases, conservative treat-
ment was effective, and in two patients with sepsis and
ACS, EA was contraindicated.
Outcomes
Eleven patients (85%) of group I had a favorable outcome,
and only two patients (15%) died due to brain edema and
herniation early in the postoperative period. In group II, a
favorable outcome was observed in 15 patients (54%),
while 4 patients (14%) had severe disability, and 9 patients
died (32%). Causes of death were: sepsis (n = 3), meningitis
(n = 1), combination of sepsis and meningitis (n =2 ) ,
brain edema and herniation (n = 1), acromegalic cardio-
myopathy (n = 1), and pulmonary thromboembolism
(n = 1). An absolute risk of having a poorer neurologic
recovery (any other below GOS 5) in patients with IAH
was 0.89, with a 95% confidence interval of 0.77 to 1.0.
T h el e n g t ho fs t a y[ L O S ]i nt h e NICU was significantly
longer in patients with IAH (p = 0.02, Table 2).
IAH developed in 19 (63.3%) survivors and in 9
(81.8%) non-survivors (p = 0.3). ACS developed in
13.3% of survivors and in 45.5% of non-survivors (p =
0.03) (Table 3). The evolution of IAP in survivors and
non-survivors during the first seven days of the post-
operative period is shown in Figure 2.
In survivors, isolated impairment of intestinal/colonic
emptying developed in 66.7% of patients; the combination
of impaired gastric emptying and impaired intestinal/colo-
nic emptying was revealed in 33.3% of patients. In non-
survivors, isolated impairment of intestinal/colonic empty-
ing developed in 9.1% of patients; the combination of
impaired gastric emptying and impaired intestinal/colonic
emptying was revealed in 90.9% of patients. Therefore, iso-
lated impairment of intestinal/colonic emptying was
observed significantly more frequently in group I (p =
0.01), whereas the combination of impaired gastric empty-
ing and impaired intestinal/colonic emptying was observed
significantly more frequently in group II (p = 0.01). Inde-
pendent risk factors such as positive fluid balance, sym-
pathomimetics, administration of narcotics, and
sympathomimetics were revealed significantly more fre-
quently in non-survivors than in survivors. Ileus persisted
significantly longer in non-survivors than in survivors,
15.3 ± 8.5 versus 8.5 ± 6.6 days (p = 0.01).
All four patients with ACS, who had received EA, sur-
vived with favorable outcomes. Three patients with ACS
and effective conservative therapy died due to causes
independent of IAH (thromboembolism, cardiomyopa-
thy, and sepsis). The other two patients with ACS, who
had not received EA, died due to sepsis and meningitis.
Discussion
A complicated postoperative period developed in 7% of
patients with SRT. Two thirds of this neurocritical care
population has IAH, which developed on the second
postoperative day. IAH correlated with worse APACHE-
II and SOFA scores, and it occurred more frequently in
non-survivors. Patients with normal IAP had better out-
comes. However, the cause-and-effect relationship
between IAP and severity of the patients’ condition
remains unclear. Severe injury to the hypothalamo-pitui-
tary axis can lead to MOD [4]. On the other hand, our
patients had high maximal IAP values, and IAH can
also be considered as a cause of MOD [5,12]. Our data
show the importance of IAP monitoring in these neuro-
critical care patients since early recognition and timely
medical management can affect outcome.
Ileus was a leading cause of IAH in our cohort. Theore-
tically, capillary leak syndrome and fluid accumulation can
also cause IAH [1,3,5]. This syndrome can be due to
decompensated hypothyroidism [13] in patients with SRT
and can lead to polyserositis with ascites, hydrothorax,
and/or hydropericardium [6,14]. In our population, severe
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received postoperative polyhormonal therapy, and the
levels of thyroid hormones in plasma were routinely con-
trolled. Also, there were no patients with ascites in our
study population.
Different types of ileus were observed: impaired intest-
inal and colonic emptying and a combined form. The lead-
ing cause of ileus was DD, and this can be explained by
the surgery site. Hypothalamic nuclei directly regulate gas-
trointestinal motility [7,15]. Furthermore, a normal thyroid
status is necessary for an adequate function of the gastro-
intestinal tract [13]. Independent risk factors had minor
importance for the ileus development in our patients,
especially narcotics, sympathomimetics, or positive fluid
balance. The last is insignificant for SRT patients because
central diabetes insipidus is a common postoperative com-
plication. Sepsis was an important risk factor for ACS. Our
results are in concordance with previous literature data
[16-18]. Hypokalemia and hypomagnesaemia developed
frequently due to glucocorticoid therapy [19].
Conservative treatment was effective in the majority of
patients with IAH, but without ACS. In ACS, on the
other hand, conservative treatment was ineffective in
two thirds of the patients. Guidelines recommend
urgent laparotomy if conservative therapy fails [5,8,20].
There are no publications on the timing and efficacy of
urgent laparotomy in patients with secondary ACS due
to neurosurgical pathology. Thoracic EA, used before
laparotomy, should therefore be considered as a safe
and effective therapeutic option.
The use of EA is generally accepted in the ICU and has
been previously described [10,21,22]. The pathophysiolo-
gical basis of thoracic EA for the treatment of ACS is: (1)
sympathetic block and accordingly, prevalence of para-
sympathetic tonus in the innervation of the gastrointest-
inal tract, (2) strong analgetic effect, (3) abdominal wall
Table 3 Characteristics of survivors and non-survivors
Survivors Non-survivors p Value
Number (patients) 30 11
Sex (male/female) 12:18 7:4 0.17
Age (mean ± SD) 46.6 ± 15.9 53.0 ± 11.3 0.8
APACHE-II (mean ± SD) 11.0 ± 4.5 18.6 ± 4.6 0.05
SOFA score (mean ± SD) 1.9 ± 1.4 4.1 ± 2.1 0.04*
Admission value of IAP
(mmHg, mean ± SD)
9.1 ± 3.9 9.6 ± 4.6 0.8
Normal IAP (patients (%)) 11 (36.7) 2 (18.2) 0.3
Maximal value of IAP
(mmHg, mean ± SD)
14.1 ± 5.6 18.2 ± 6.9 0.06
Minimal value of APP
(mmHg, mean ± SD)
80.9 ± 8.8 74.9 ± 7.7 0.05
IAH (patients (%)) 19 (63.3) 9 (81.8) 0.3
ACS (patients) 4 (13.3) 5 (45.5) 0.03*
Ileus 23 (76.7) 11 (100) 0.08
Type of ileus (patients (%))
Impaired gastric emptying 0 0
Impaired intestinal and colonic emptying 20 (66.7) 1 (9.1) 0.01*
Combined form 10 (33.3) 10 (90.9) 0.01*
Onset time of ileus (postoperative day) 2.6 ± 1.6 1.6 ± 0.7 0.06
Duration of ileus (days) 8.5 ± 6.6 15.3 ± 8.5 0.01*
Risk factors of ileus (patients (%))
DD 25 (83.3) 8 (72.7) 0.4
Independent risk factors (patients (%))
Narcotics 0 2 (18.2) 0.02*
Sympathomimetics 12 (40) 9 (81.8) 0.02*
Positive fluid balance 1 (3.3) 6 (54.5) 0.0001*
Sepsis 2 (6.7) 6 (54.5) 0.0006*
Hypokalemia, hypomagnesaemia 19 (63.3) 9 (81.8) 0.3
*Significant difference. SD, standard deviation; APACHE-II, acute physiology and chronic health evaluation, and SOFA, sequential organ failure assessment, scores
on ICU admission; IAP, intra-abdominal pressure; APP, abdominal perfusion pressure; IAH, intra-abdominal hypertension; ACS, abdominal compartment syndrome;
DD, diencephalon dysfunction.
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flow, gastric mucosal perfusion, improvement of tissue
oxygenation, and (5) prevention of bacterial translocation
[22-25]. These mechanisms can interrupt the deleterious
pathological processes caused by ACS. We showed that
the use of EA can be effective in a selected group of
patients. In these patients, the IAP normalized within
several hours, and signs of MOD regressed within 1 to 2
days. The duration of IAH in patients with EA was signif-
icantly shorter than that in patients without EA. We
could not perform EA in two septic patients with ineffec-
tive conservative treatment for ACS. Traditionally, sepsis
is a contraindication for EA due to an increased risk of
infectious complications [21,26]. All patients with ACS,
who did not receive EA, died, irrespective of the duration
of ACS. These data allow us to conclude the following:
(1) early thoracic EA can be an effective treatment option
for secondary ACS in neurosurgical patients; and (2) if
the main cause of ACS in neurosurgical patients is sepsis,
the only effective method of ACS treatment would prob-
ably be urgent laparotomy.
To our knowledge, this is the first study to investigate
secondary ACS in patients with SRT. Our study has sev-
eral serious limitations. First, 41 patients are still a small
number for a meaningful statistical analysis, especially
concerning the calculation of the risk of unfavorable out-
comes and death in patients with IAH. Second, it is a sin-
gle-center study. Third, we only performed intermittent
measurements of IAP, not continuous monitoring, which
could have changed the therapeutic approach and accord-
ingly, the results. Fourth, four patients with EA are a small
number for decision-making about the significance of EA
for ACS treatment.
Conclusions
The development of IAH is common in patients after
SRT surgery during a complicated postoperative period.
If conservative treatment is ineffective, EA can be
attempted in patients with secondary ACS when it is
not contraindicated. Further studies are warranted.
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